Cutler Group LP Cytom X Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Oct 27, 2020	SELL	$6.55 - $8.83 $1,310 - $1,766	-200 Reduced 16.67%	1,000 $3,000
Q2 2020 Jul 22, 2020	BUY	$7.4 - $14.64 $3,700 - $7,320	500 Added 71.43%	1,200 $3,000
Q4 2018 Feb 05, 2019	SELL	$12.69 - $18.61 $5,076 - $7,444	-400 Reduced 36.36%	700 $2,000
Q3 2018 Nov 07, 2018	BUY	$18.04 - $26.41 $7,216 - $10,564	400 Added 57.14%	1,100 $7,000
Q2 2018 Aug 10, 2018	BUY	$21.38 - $29.68 $2,138 - $2,968	100 Added 16.67%	700 $6,000
Q1 2018 May 11, 2018	SELL	$21.76 - $34.22 $4,352 - $6,844	-200 Reduced 25.0%	600 $1,000
Q4 2017 Jan 17, 2018	BUY	$19.0 - $23.09 $15,200 - $18,472	800	800 $1,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.